PricingLoginNewsroom
Vol. II — No. 184Remarkable People · Exceptional CompaniesToday's Edition

hinge-bio

(2)
AllCompaniesPeopleStoriesProducts
Legend
Barry Selick’s Second Act Is a Return to the Bench-to-Business Handoff
Founder · Investor · Operator

Barry Selick’s Second Act Is a Return to the Bench-to-Business Handoff

After decades moving between lab science, venture capital, public-company leadership and university innovation, Barry Selick is back inside a small biotech - carrying a career’s worth of pattern recognition into Hinge Bio’s clinical turn.

barry-selick · harold-selickRead →
Legend
JC
Executive · Operator · Advisor

Josh Carle

Josh Carle is the Chief Business Officer of Hinge Bio, a Burlingame, California biotech building multivalent, multispecific antibody therapies on its GEM-DIMER platform. A dealmaker by trade, he has led or advised more than fifty strategic transactions worth over $2 billion in disclosed deal value, moving from Pfizer Oncology and Daiichi Sankyo to immuno-oncology startup Triumvira before joining Hinge Bio in January 2023 to steer its lead lupus program toward the clinic.

josh-carle · joshua-carleRead →